Vascular risk factors for central retinal artery occlusion

Eye

Volumn 24, Issue 4, 2010, Pages 678-681

  Rudkin, A K ^a   Lee, A W ^a   Chen, C S ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

(MeSH):retinal artery occlusion; Arteriosclerosis; Carotid; Carotid artery stenosis; Endarterectomy; Risk factors

Indexed keywords

ACUTE CORONARY SYNDROME; AGED; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; ARTICLE; ATHEROSCLEROSIS; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CENTRAL RETINA ARTERY OCCLUSION; CLINICAL ARTICLE; COMORBIDITY; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FAMILY HISTORY; FOLLOW UP; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HIGH RISK POPULATION; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; RISK ASSESSMENT; SMOKING; STENT; STROKE; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK;

EID: 77951142365     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2009.142     Document Type: Article

References (19)

1. Rumelt S, Dorenboim Y, Rehany U. Aggressive systematic treatment for central retinal artery occlusion. Am J Ophthalmol 1999; 128: 733-738.
2. Chen C, Lee A. Management of acute central retinal artery occlusion. Nat Clin Pract Neurol 2008; 4: 376-383.
3. Schmidt D, Schulte-Mönting J, Schumacher M. Prognosis of central retinal artery occlusion: local intraarterial fibrinolysis versus conservative treatment. AJNR Am J Neuroradiol 2002; 23: 1301-1307.
4. Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 2007; 6: 1063-1072.
5. Giannuzzi P, Temporelli PL, Marchioli R. Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network. Arch Intern Med 2008; 168: 2194-2204.
6. Chawluk JB, Kushner MJ, Bank WJ, Silver FL, Jamieson DG, Bosley TM et al. Atherosclerotic carotid artery disease in patients with retinal ischemic syndromes. Neurology 1988; 38: 858.
7. Recchia FM, Brown GC. Systemic disorders associated with retinal vascular occlusion. Curr Opin Ophthalmol 2000; 11: 462-467.
8. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325: 445-453.
9. Gaunt M, Davis P, Lee AG, Lee MS. Getting to the heart of the matter. Surv Ophthalmol 2008; 53: 636-640.
10. Babikian V, Wijman C, Koleini B. Retinal ischemia and embolism. Etiologies and outcomes based on a prospective study. Cerebrovasc Dis 2001; 12: 108-113.
11. Wong TY, Klein R. Retinal arteriolar emboli: epidemiology and stroke risk. Curr Opin Ophthalmol 2002; 13: 142-146.
12. Schmidt D, Hetzel A, Geibel-Zehender A, Schulte-Mönting J. Systemic diseases in non-inflammatory branch and central retinal artery occlusion-an overview of 416 patients. Eur J Med Res 2007; 12: 595-603.
13. Barnett H, Taylor D, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998; 339: 1415-1425.
14. Graham GD. Secondary stroke prevention: from guidelines to clinical practice. J Natl Med Assoc 2008; 100: 1125-1137.
15. Paciaroni M, Hennerici M, Agnelli G, Bogousslavsky J. Statins and stroke prevention. Cerebrovasc Dis 2007; 24: 170-182.
16. Fraser SG, Adams W. Interventions for acute non-arteritic central retinal artery occlusion. Cochrane Database Syst Rev 2009; (1): CD001989.
17. Hayreh S, Zimmermanb B, Kimuraa A, Sanon A. Central retinal artery occlusion. Retinal survival time. Exp Eye Res 2004; 78: 723-736.
18. Romano JG, Sacco RL. Progress in secondary stroke prevention. Ann Neurol 2008; 63: 418-427.
19. Campbell DJ. A review of Perindopril in the reduction of cardiovascular events. Vasc Health Risk Manag 2006; 2: 117-124.